Chaperonin 10 Variants

The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated mol...

Full description

Saved in:
Bibliographic Details
Main Authors LAMBERT, DANIEL, SCOTT, VAN HEUMEN, WALTER, RENE, ANTONIUS, WARD, LINDA ALLISON, HOWARD, CHRISTOPHER BRUCE, JAMES, ANDREW LEIGH, RALSTON, KYLIE, JANE, BROWN, RICHARD, JAMES, STOK, JEANETTE ELIZABETH, DE BAKKER, CHRISTOPHER, JOHN, NAYLOR, DEAN, JASON
Format Patent
LanguageEnglish
Published 30.07.2015
Online AccessGet full text

Cover

More Information
Summary:The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (DAMPs).
Bibliography:Application Number: SG20151005023T